These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 19737962

  • 1. High-dose zoledronic acid impacts bone remodeling with effects on osteoblastic lineage and bone mechanical properties.
    Pozzi S, Vallet S, Mukherjee S, Cirstea D, Vaghela N, Santo L, Rosen E, Ikeda H, Okawa Y, Kiziltepe T, Schoonmaker J, Xie W, Hideshima T, Weller E, Bouxsein ML, Munshi NC, Anderson KC, Raje N.
    Clin Cancer Res; 2009 Sep 15; 15(18):5829-39. PubMed ID: 19737962
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Skeletal remodeling following clinically relevant radiation-induced bone damage treated with zoledronic acid.
    Hui SK, Fairchild GR, Kidder LS, Sharma M, Bhattacharya M, Jackson S, Le C, Yee D.
    Calcif Tissue Int; 2012 Jan 15; 90(1):40-9. PubMed ID: 22083107
    [Abstract] [Full Text] [Related]

  • 4. Zoledronic acid at subtoxic dose extends osteoblastic stage span of primary human osteoblasts.
    Zara S, De Colli M, di Giacomo V, Zizzari VL, Di Nisio C, Di Tore U, Salini V, Gallorini M, Tetè S, Cataldi A.
    Clin Oral Investig; 2015 Apr 15; 19(3):601-11. PubMed ID: 25055744
    [Abstract] [Full Text] [Related]

  • 5. Bolus or weekly zoledronic acid administration does not delay endochondral fracture repair but weekly dosing enhances delays in hard callus remodeling.
    McDonald MM, Dulai S, Godfrey C, Amanat N, Sztynda T, Little DG.
    Bone; 2008 Oct 15; 43(4):653-62. PubMed ID: 18582604
    [Abstract] [Full Text] [Related]

  • 6. Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro.
    Schindeler A, Little DG.
    Biochem Biophys Res Commun; 2005 Dec 16; 338(2):710-6. PubMed ID: 16243296
    [Abstract] [Full Text] [Related]

  • 7. Optimal timing of a single dose of zoledronic acid to increase strength in rat fracture repair.
    Amanat N, McDonald M, Godfrey C, Bilston L, Little D.
    J Bone Miner Res; 2007 Jun 16; 22(6):867-76. PubMed ID: 17371160
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Skeletal effects of zoledronic acid in an animal model of chronic kidney disease.
    Allen MR, Chen NX, Gattone VH, Chen X, Carr AJ, LeBlanc P, Brown D, Moe SM.
    Osteoporos Int; 2013 Apr 16; 24(4):1471-81. PubMed ID: 22907737
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early inhibitory effects of zoledronic acid in tooth extraction sockets in dogs are negated by recombinant human bone morphogenetic protein.
    Gerard DA, Carlson ER, Gotcher JE, Pickett DO.
    J Oral Maxillofac Surg; 2014 Jan 16; 72(1):61-6. PubMed ID: 23891015
    [Abstract] [Full Text] [Related]

  • 12. Raloxifene Improves Bone Mechanical Properties in Mice Previously Treated with Zoledronate.
    Meixner CN, Aref MW, Gupta A, McNerny EMB, Brown D, Wallace JM, Allen MR.
    Calcif Tissue Int; 2017 Jul 16; 101(1):75-81. PubMed ID: 28246928
    [Abstract] [Full Text] [Related]

  • 13. Effects of short-term zoledronic acid treatment on bone remodeling and healing at surgical sites in the maxilla and mandible of aged dogs.
    Huja SS, Mason A, Fenell CE, Mo X, Hueni S, D'Atri AM, Fernandez SA.
    J Oral Maxillofac Surg; 2011 Feb 16; 69(2):418-27. PubMed ID: 21122971
    [Abstract] [Full Text] [Related]

  • 14. Influence of early zoledronic acid administration on bone marrow fat in ovariectomized rats.
    Li GW, Xu Z, Chang SX, Zhou L, Wang XY, Nian H, Shi X.
    Endocrinology; 2014 Dec 16; 155(12):4731-8. PubMed ID: 25243855
    [Abstract] [Full Text] [Related]

  • 15. Zoledronic acid decreases bone formation without causing osteocyte death in mice.
    Huja SS, Fernandez SA, Phillips C, Li Y.
    Arch Oral Biol; 2009 Sep 16; 54(9):851-6. PubMed ID: 19591974
    [Abstract] [Full Text] [Related]

  • 16. Comparison of the effects of genistein and zoledronic acid on the bone loss in OPG-deficient mice.
    Liu J, Xu K, Wen G, Guo H, Li S, Wu X, Dai R, Sheng Z, Liao E.
    Bone; 2008 May 16; 42(5):950-9. PubMed ID: 18337202
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.